MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,668,000 | -29.3% | 540 | +275.0% | 0.08% | +7.8% |
Q1 2021 | $3,774,000 | +188600.0% | 144 | +41.2% | 0.08% | +3750.0% |
Q4 2020 | $2,000 | -66.7% | 102 | -85.0% | 0.00% | -60.0% |
Q3 2019 | $6,000 | -79.3% | 678 | -72.2% | 0.01% | -79.2% |
Q2 2019 | $29,000 | +1350.0% | 2,441 | +2316.8% | 0.02% | +1100.0% |
Q3 2018 | $2,000 | -71.4% | 101 | -77.1% | 0.00% | -71.4% |
Q2 2018 | $7,000 | +133.3% | 441 | +107.0% | 0.01% | +133.3% |
Q1 2018 | $3,000 | – | 213 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |